Purple Biotech Ltd.-ADRPPBT
13F holders, Q3 2024 (September 30)10holders
$5.55avg. 13F price*
At the end of Q3 2024, 10 institutions reported holding Purple Biotech Ltd.-ADR (PPBT) in their 13F filings. The largest holders were Armistice Capital, LLC ($877K), Morgan Stanley ($45K) and BNP Paribas Financial Markets ($20K).
- Company
- Purple Biotech Ltd.-ADR
- CUSIP
- 74638P208
- Latest filing quarter
- Q4 2025
History
Number of 13F holders
Total Exit/New Position Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $22K |
| Exits | 0 | $0 |
Ownership 10 holders
| Armistice Capital, LLC | 0.02% | Add +132.7% | 158,000 | $877K |
| Morgan Stanley | 0.00% | Reduce -20.6% | 8,055 | $45K |
| BNP Paribas Financial Markets | 0.00% | New | 3,675 | $20K |
| Tower Research Capital LLC (TRC) | 0.00% | New | 254 | $1K |
| TD Waterhouse Canada Inc. | 0.00% | No change | 200 | $1K |
| Royal Bank of Canada | 0.00% | Reduce -0.8% | 107 | $1K |
| JPMorgan Chase & Co. | 0.00% | Reduce -2.2% | 42 | $234 |
| Group One Trading LLC | 0.00% | No change | 20 | $111 |
| Global Retirement Partners, LLC | 0.00% | Reduce -4.8% | 16 | $89 |
| Danske Bank A/S | 0.00% | New | 4 | $22 |
"% of holder's portfolio" is PPBT's weight in each manager's 13F, not the share of Purple Biotech Ltd.-ADR the manager owns.